Abstract
Biliary duct and gallbladder tumors lead to 3.320 annual deaths in US, according to American Cancer Society and is highly prevalent in Latin America. Curative treatment is based on surgery. Most patients present with unresectable disease with expected survival inferior to 12 months, even when treated with chemotherapy. Identification of those who will benefit from treatment is essential,…